Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TRIB
TRINITY BIOTECH PLC
NASDAQ
$9.68
▼ DOWN 0.72% (-0.07)

KEY STATISTICS

Market Cap$196.03 M
52w High$52.50
52w Low$7.94
Dividend Yield0.25%
FrequencyAnnual
P/E-0.16
Volume6.50K
Shares Out.20.25M

COMPANY

LEADERSHIP

John Gillard
CHIEF EXECUTIVE
John Gillard

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 21, 1992
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
287

UPCOMING EARNINGS

DateSep 3, 2026
DayThursday
Rev. Est.$10.31M
SEP
3
THU

SPLIT RECORD

DATETYPERATIO
2026-07-24Reverse1:30
2025-08-27Reverse1:5
2024-02-23Reverse1:5
2005-06-02Reverse1:4

PRICE

$9.68 ▼ DOWN 0.72% (−$0.07)
OVERLAYS
$9.53$9.60$9.67$9.759:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM9.68

About Trinity Biotech plc

https://www.trinitybiotech.com ↗

Trinity Biotech plc develops, manufactures, and markets diagnostic products for infectious diseases, diabetes, and other conditions across global clinical and point-of-care markets, serving health authorities, labs, and research institutions.

INDUSTRY

Medical - Specialties

A PRODUCT TRINITY BIOTECH PLC IS KNOWN FOR

CGM+ Wearable Biosensor
CGM+ Wearable Biosensor

Trinity Biotech's upcoming CGM+ is a multi-sensor wearable biosensor launching in mid-2026, tracking glucose, heart activity, temperature, and activity to advance chronic disease management, digital health, and wellness.

COMPETITORS

COMPETITOR
ABT COMPARE
DXCM COMPARE
MDT COMPARE
SENS COMPARE

Revenue by Products

IconPRODUCTQ2-2022
Clinical Laboratory$29.53M
Laboratory Services$3.7M

Revenue by Geography

MapREGIONFY2021FY2022FY2023FY2025
Americas$57.8M — — —
USA— $76.62M $66.85M ▼$51.98M ▼
Asia Africa$25.5M — — —
IRELAND— $25.1M $12.72M ▼$15M ▲
Europe including Ireland$9.66M — — —

INSTITUTIONAL OWNERSHIP

SHARES OWNED
30.44%
HOLDERS
55
TOP 12 OF 55 · RANKED BY POSITION SIZE
Perceptive Advisors LLC
1.8M sh · $1.86M
Janus Henderson Investors Us LLC
1.4M sh · $8.45M
Hunter Associates Investment Management LLC
661.2K sh · $251K
Russell Frank Co/
453.0K sh · $5.28M
Chartwell Investment Partners/Pa
400.2K sh · $9.7M
Emerald Acquisition Ltd.
388.5K sh · $5.14M
Adirondack Funds
302.3K sh · $3.46M
Yorkville Advisors Global, LP
225.0K sh · $122K
Renaissance Technologies LLC
171.4K sh · $178.22K
Jay Jeffrey R
163.1K sh · $2.75K
Williams & Novak, LLC
140.5K sh · $54.64K
Mindshare Capital Management, LLC
50.5K sh · $853

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
O'Caoimh Ronan
— · —
2026-03-18
★
DIRECTOR
O'Caoimh Ronan
— · 101.5K shares
2021-06-14
★
DIRECTOR
O'Caoimh Ronan
— · 60.0K shares
2022-11-17
★
DIRECTOR
O'Caoimh Ronan
— · 16.7K shares
2023-03-20

SECTORS PEERS

PEERPRICE
MRKR$1.37COMPARE
ADVB$9.70COMPARE
SINT$1.50COMPARE
EVGN$0.55COMPARE
BGLC$1.55COMPARE
XAIR$4.48COMPARE
TNON$5.00COMPARE